{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:58:59Z","timestamp":1790801939191,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05957-8","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:42:29Z","timestamp":1790754149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypersensitivity reactions to pertuzumab\/trastuzumab fixed-dose combination (PHESGO\u00ae): successful management with a simplified 9-step subcutaneous desensitization protocol"],"prefix":"10.1007","author":[{"given":"Mattia","family":"Cristallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Filieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia Stefania","family":"Stucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Chaoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Albanesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cataldo","family":"Piarulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Di Girolamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"5957_CR1","doi-asserted-by":"crossref","unstructured":"Bavbek S, Lee MJ (2017) Subcutaneous injectable drugs hypersensitivity and desensitization: insulin and monoclonal antibodies. Immunol Allergy Clin North Am 37(4):761\u2013771","DOI":"10.1016\/j.iac.2017.06.001"},{"issue":"6","key":"5957_CR2","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","volume":"124","author":"PJ Brennan","year":"2009","unstructured":"Brennan PJ, Rodriguez Bouza T, Hsu FI, Sloane DE, Castells MC (2009) Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol 124(6):1259\u20131266","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"5957_CR3","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00262-012-1273-x","volume":"61","author":"M Castells","year":"2012","unstructured":"Castells M, Sancho-Serra MC, Simarro M (2012) Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization. Cancer Immunol Immunother 61(9):1575\u201384","journal-title":"Cancer Immunol Immunother"},{"issue":"6924","key":"5957_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature01392","volume":"421","author":"HS Cho","year":"2003","unstructured":"Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW Jr, Leahy DJ (2003) Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421(6924):756\u201360","journal-title":"Nature"},{"key":"5957_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5114\/ada.2024.138836","volume":"41","author":"M Cristallo","year":"2024","unstructured":"Cristallo M, Chaoul N, Albanesi M et al (2024) Allergy to ceftazi- dime\/avibactam: diagnosis and desensitization. Adv Dermatol Allergol 41:239\u2013241","journal-title":"Adv Dermatol Allergol"},{"issue":"6","key":"5957_CR6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.5114\/ada.2024.145434","volume":"41","author":"M Cristallo","year":"2024","unstructured":"Cristallo M, Spataro F, Chaoul N, Nettis E, Di Girolamo A (2024) Rapid desensitization for human serum albumin (Grifols\u00ae) hypersensitivity. Adv Dermatol Allergol 41(6):634\u2013636","journal-title":"Adv Dermatol Allergol"},{"key":"5957_CR7","doi-asserted-by":"crossref","unstructured":"D\u2019Alessio A, Cecchini S, Di Mauro D, Geroli L, Villa S, Quadri A, Resta D, Fortugno C (2016) Cutaneous toxicity from epidermal growth factor receptor inhibitors: would a subcutaneous desensitization be helpful? Case report. Tumori","DOI":"10.5301\/tj.5000579"},{"issue":"4","key":"5957_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1535-6108(04)00083-2","volume":"5","author":"MC Franklin","year":"2004","unstructured":"Franklin MC, Carey KD, Vajdos FF, Leahy DJ, de Vos AM, Sliwkowski MX (2004) Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5(4):317\u201328","journal-title":"Cancer Cell"},{"issue":"2","key":"5957_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jaip.2015.10.007","volume":"4","author":"D Gonz\u00e1lez-de-Olano","year":"2016","unstructured":"Gonz\u00e1lez-de-Olano D, Morgado JM, Ju\u00e1rez-Guerrero R, S\u00e1nchez-Mu\u00f1oz L, Letellez-Fern\u00e1ndez J, Mal\u00f3n-Gim\u00e9nez D, Castells MC (2016) Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization. J Allergy Clin Immunol Pract 4(2):338\u201340","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"5957_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jaci.2018.02.018","volume":"142","author":"GAC Isabwe","year":"2018","unstructured":"Isabwe GAC, Garcia Neuer M, de Las Vecillas Sanchez L, Lynch DM, Marquis K, Castells M (2018) Hypersensitivity reactions to therapeutic monoclonal antibodies: phenotypes and endotypes. J Allergy Clin Immunol 142(1):159-170.e2","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"5957_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.18176\/jiaci.0761","volume":"32","author":"JA Lemus Calder\u00f3n","year":"2022","unstructured":"Lemus Calder\u00f3n JA, Tapia de Pedro G, Marchan Mart\u00edn E, Guzm\u00e1n Rodriguez R, Caba\u00f1es Higuero MN, Senent S\u00e1nchez CJ (2022) Desensitization to pertuzumab with a positive skin test result in a mixed-phenotype hypersensitivity reaction. J Investig Allergol Clin Immunol 32(4):320\u2013321","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"5957_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2026.100651","volume":"5","author":"S Palazzo","year":"2026","unstructured":"Palazzo S, Albanesi M, Cristallo M, Pugliese F, Chaoul N, Caffarella G, Cinquantasei A, Piarulli C, Cinquantasei M, Aprigliano M, Caldelli R, Loconsole C, Tafuri S, Nettis E, Di Girolamo A (2026) Response to venom immunotherapy: exploratory retrospective machine learning clustering analysis. J Allergy Clin Immunol Glob 5(3):100651","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"4","key":"5957_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.18176\/jiaci.0981","volume":"34","author":"MJ Pe\u00f1alver","year":"2024","unstructured":"Pe\u00f1alver MJ, Bautista-Villanueva S, Barranco R, Crespo JF, Mielgo R (2024) Successful subcutaneous desensitization to certolizumab Pegol. J Investig Allergol Clin Immunol 34(4):272\u2013274","journal-title":"J Investig Allergol Clin Immunol"},{"key":"5957_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0091-6749(88)90996-7","volume":"82","author":"MM Pienkowski","year":"1988","unstructured":"Pienkowski MM, Kazmier WJ, Adkinson NF Jr. (1988) Basophil histamine release remains unaffected by clinical desensitization to penicillin. J Allergy Clin Immunol 82:171\u20138","journal-title":"J Allergy Clin Immunol"},{"issue":"16","key":"5957_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612577","volume":"24","author":"R Rodr\u00edguez-P\u00e9rez","year":"2023","unstructured":"Rodr\u00edguez-P\u00e9rez R, de Las Vecillas L, Caba\u00f1as R, Bell\u00f3n T (2023) Tools for etiologic diagnosis of drug-induced allergic conditions. Int J Mol Sci 24(16):12577","journal-title":"Int J Mol Sci"},{"issue":"6 Suppl","key":"5957_CR16","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1016\/j.anai.2024.08.513","volume":"133","author":"V Saldana-Fraire","year":"2024","unstructured":"Saldana-Fraire V, Romo De Le\u00f3n L, Estrada-Mendizabal R, Gonzalez-Estrada A, Canel Paredes A (2024) Desensitization to pertuzumab\/trastuzumab\/hyaluronidase-zzxf in a patient with Hymenoptera anaphylaxis. Ann Allergy Asthma Immunol 133(6 Suppl):S120\u2013S121. https:\/\/doi.org\/10.1016\/j.anai.2024.08.513","journal-title":"Ann Allergy Asthma Immunol"},{"key":"5957_CR17","doi-asserted-by":"crossref","unstructured":"Soyer OU, Akdis M, Akdis CA (2011) Mechanisms of subcutaneous allergen immunotherapy. Immunol Allergy Clin North Am 31(2):175\u201390 vii-viii\u00a0","DOI":"10.1016\/j.iac.2011.02.006"},{"key":"5957_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejca.2022.09.024","volume":"178","author":"SM Swain","year":"2023","unstructured":"Swain SM, Tan AR, Gianni L, Kuemmel S, Dang CT, Schneeweiss A, O\u2019Shaughnessy J, Liu H, Aguila C, Heeson S, Macharia H, Yang K, Restuccia E, Loibl S (2023) Incidence and severity of anaphylaxis and hypersensitivity in trials of intravenous pertuzumab plus trastuzumab or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection for HER2-positive breast cancer. Eur J Cancer 178:70\u201381","journal-title":"Eur J Cancer"},{"key":"5957_CR19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/curroncol32120658","volume":"32","author":"K Yanagihara","year":"2025","unstructured":"Yanagihara K, Yoshida M, Awaji K, Yamakawa T, Kato S, Tamura M, Nagata K (2025) Real-world outcomes of subcutaneous PHESGO\u00ae in HER2-positive breast cancer: pathological response, sequencing, and safety. Curr Oncol 32:658","journal-title":"Curr Oncol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05957-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05957-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05957-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:04:00Z","timestamp":1790798640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05957-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":19,"alternative-id":["5957"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05957-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"25 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from the patient for the publication of identifying information and images.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}